Viewing Study NCT00034528


Ignite Creation Date: 2025-12-26 @ 11:13 AM
Ignite Modification Date: 2025-12-31 @ 5:53 PM
Study NCT ID: NCT00034528
Status: TERMINATED
Last Update Posted: 2013-05-01
First Post: 2002-04-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Stem Cell Transplantation After Reduced-Dose Chemotherapy for Patients With Sickle Cell Disease or Thalassemia
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module